106 related articles for article (PubMed ID: 10844561)
61. Why drug exposure is frequently associated with T-cell mediated cutaneous hypersensitivity reactions.
Line J; Saville E; Meng X; Naisbitt D
Front Toxicol; 2023; 5():1268107. PubMed ID: 37795379
[TBL] [Abstract][Full Text] [Related]
62. Activation of Human CD8+ T Cells with Nitroso Dapsone-Modified HLA-B*13:01-Binding Peptides.
Almutairi M; Lister A; Zhao Q; Line J; Adair K; Tailor A; Waddington J; Clarke E; Gardner J; Thomson P; Harper N; Sun Y; Sun L; Ostrov DA; Liu H; MacEwan DJ; Pirmohamed M; Meng X; Zhang F; Naisbitt DJ
J Immunol; 2023 Apr; 210(8):1031-1042. PubMed ID: 36881872
[TBL] [Abstract][Full Text] [Related]
63. Genomic Risk Factors Driving Immune-Mediated Delayed Drug Hypersensitivity Reactions.
Li Y; Deshpande P; Hertzman RJ; Palubinsky AM; Gibson A; Phillips EJ
Front Genet; 2021; 12():641905. PubMed ID: 33936169
[TBL] [Abstract][Full Text] [Related]
64. 4,4'-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor.
Lee JH; An HK; Sohn MG; Kivela P; Oh S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32824985
[TBL] [Abstract][Full Text] [Related]
65. Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.
Oesch F; Fabian E; Landsiedel R
Arch Toxicol; 2018 Aug; 92(8):2411-2456. PubMed ID: 29916051
[TBL] [Abstract][Full Text] [Related]
66. Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.
Oesch F; Fabian E; Guth K; Landsiedel R
Arch Toxicol; 2014 Dec; 88(12):2135-90. PubMed ID: 25370008
[TBL] [Abstract][Full Text] [Related]
67. Idiosyncratic adverse drug reactions: current concepts.
Uetrecht J; Naisbitt DJ
Pharmacol Rev; 2013 Apr; 65(2):779-808. PubMed ID: 23476052
[TBL] [Abstract][Full Text] [Related]
68. Bullous allergic drug eruption with presence of myeloperoxidase and reorganization of the dermal vessels observed by using CD34 and collagen IV antibodies.
Abreu-Velez AM; Klein DA; Smoller BR; Howard MS
N Am J Med Sci; 2011 Feb; 3(2):82-4. PubMed ID: 22540071
[TBL] [Abstract][Full Text] [Related]
69. A case of toxic epidermal necrolysis (ten) with severe chronic ocular complications in a healthy 46-year-old woman.
Voltan A; Azzena B
Ann Burns Fire Disasters; 2010 Jun; 23(2):81-7. PubMed ID: 21991203
[TBL] [Abstract][Full Text] [Related]
70. Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity.
Wang D; Para MF; Koletar SL; Sadee W
Pharmacogenet Genomics; 2011 Oct; 21(10):652-64. PubMed ID: 21878835
[TBL] [Abstract][Full Text] [Related]
71. Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.
Bhusari S; Abouraya M; Padilla ML; Pinkerton ME; Drescher NJ; Sacco JC; Trepanier LA
Arch Toxicol; 2010 Aug; 84(8):597-607. PubMed ID: 20221587
[TBL] [Abstract][Full Text] [Related]
72. New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.
Paquet P; Piérard GE
Drug Saf; 2010 Mar; 33(3):189-212. PubMed ID: 20158284
[TBL] [Abstract][Full Text] [Related]
73. Current understanding of delayed anticonvulsant hypersensitivity reactions.
Krauss G
Epilepsy Curr; 2006; 6(2):33-7. PubMed ID: 16604195
[TBL] [Abstract][Full Text] [Related]
74. Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts.
Bhaiya P; Roychowdhury S; Vyas PM; Doll MA; Hein DW; Svensson CK
Toxicol Appl Pharmacol; 2006 Sep; 215(2):158-67. PubMed ID: 16603214
[TBL] [Abstract][Full Text] [Related]
75. Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin.
Roychowdhury S; Svensson CK
AAPS J; 2005 Dec; 7(4):E834-46. PubMed ID: 16594635
[TBL] [Abstract][Full Text] [Related]
76. Role of bioactivation in drug-induced hypersensitivity reactions.
Sanderson JP; Naisbitt DJ; Park BK
AAPS J; 2006 Feb; 8(1):E55-64. PubMed ID: 16584134
[TBL] [Abstract][Full Text] [Related]
77. N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.
Hein DW
Oncogene; 2006 Mar; 25(11):1649-58. PubMed ID: 16550165
[TBL] [Abstract][Full Text] [Related]
78. Combination exposure to zidovudine plus sulfamethoxazole-trimethoprim diminishes B-lymphocyte immune responses to Pneumocystis murina infection in healthy mice.
Feola DJ; Garvy BA
Clin Vaccine Immunol; 2006 Feb; 13(2):193-201. PubMed ID: 16467325
[TBL] [Abstract][Full Text] [Related]
79. Polymorphism of N-acetyltransferase 1 and correlation between genotype and phenotype in a Thai population.
Kukongviriyapan V; Prawan A; Warasiha B; Tassaneyakul W; Aiemsa-ard J
Eur J Clin Pharmacol; 2003 Aug; 59(4):277-81. PubMed ID: 12879167
[TBL] [Abstract][Full Text] [Related]
80. Immunopharmacology of hypersensitivity reactions to drugs.
Naisbitt DJ; Pirmohamed M; Park BK
Curr Allergy Asthma Rep; 2003 Jan; 3(1):22-9. PubMed ID: 12542989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
